Vor Biopharma Inc. (VOR)
NASDAQ: VOR · IEX Real-Time Price · USD
2.370
+0.160 (7.24%)
At close: Mar 28, 2024, 4:00 PM
2.330
-0.040 (-1.69%)
After-hours: Mar 28, 2024, 6:19 PM EDT

Vor Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Cash & Equivalents
33.7760.12122.2150.18.030.93
Short-Term Investments
105.82172.5487.67000
Cash & Cash Equivalents
139.59232.66209.8850.18.030.93
Cash Growth
-40.00%10.85%318.94%524.27%763.83%-
Other Current Assets
1.224.294.52-0.99-0.490.01
Total Current Assets
140.8236.95214.449.117.540.94
Property, Plant & Equipment
50.157.0822.5221.850.730.07
Other Long-Term Assets
7.235.345.674.961.560
Total Long-Term Assets
57.3262.4228.1926.82.290.07
Total Assets
198.13299.37242.5975.919.831.01
Accounts Payable
0.821.771.552.360.690.87
Current Debt
3.833.271.840.8604.46
Other Current Liabilities
10.938.086.776.981.492.45
Total Current Liabilities
15.5713.1210.1510.212.197.77
Long-Term Debt
31.8335.6416.1717.4300
Total Long-Term Liabilities
31.8335.6416.1717.4300
Total Liabilities
47.448.7626.3327.642.197.77
Total Debt
35.6638.9118.0118.2904.46
Debt Growth
-8.36%116.02%-1.53%---
Retained Earnings
-340.08-222.22-130.12-61.22-17.89-7.05
Comprehensive Income
-0.08-0.770000
Shareholders' Equity
150.72250.61216.26-59.07-17.43-6.77
Net Cash / Debt
103.93193.75191.8731.818.03-3.53
Net Cash / Debt Growth
-46.36%0.98%503.27%296.32%--
Net Cash Per Share
1.554.905.74148.865.13-2.96
Working Capital
125.23223.83204.2538.95.35-6.84
Book Value Per Share
2.246.346.47-276.45-11.15-5.67
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).